The term sarcopenia, derived from the Greek words sarx for flesh and penia for loss, was first
introduced by Rosenberg 1 in 1989 to describe the loss of muscle mass that accompanies …

Loss of skeletal muscle mass and strength is apparent as early as the 4th decade of life and
progresses linearly with increasing age [1, 2]. The term sarcopenia, first introduced by Irwin …

Sarcopenia is a progressive systemic skeletal muscle disorder characterized by a
pathological decline in muscle strength, quantity, and quality, which frequently affects the …

In the context of the management of the elderly patient with cancer, currently, a key topic
may be expressed by sarcopenia. Sarcopenia in its various definitions and ambiguities in …

Sarcopenia, defined as loss of muscle mass, strength and physical performance, is a
hallmark of aging and is invariably associated with perturbation of amino acid metabolism …

Clinicians often believe that cachexia is caused by cancer and anorexia as a toxicity of
chemotherapy or targeted anti-cancer agents. It is now recognized that chemotherapy and …

Sarcopenia has been associated with several negative clinical outcomes in cancer.
However, the consequences of sarcopenic obesity, a condition of combined sarcopenia and …

Background Patients with advanced cancer often experience muscle wasting (sarcopenia),
yet little is known about the characteristics associated with sarcopenia and the relationship …

Importance Progressive loss of muscle mass and strength, known as sarcopenia, is a well-
known phenomenon of aging; however, little is known about the trajectory of sarcopenia …

Body composition, defined as the proportions and distribution of lean and fat tissues in the
human body, is an emergent theme in clinical oncology. Severe muscle depletion …